Core Scientific Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Core Scientific Inc's ROI in the second quarter of 2026?
Core Scientific Inc had a negative return on investment (ROI) of -90.62%, due to the net loss of $-1 billion, during the twelve months ending in the second quarter of 2026.

Within the Financial sector 35 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 2264 to 3915.

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Investment Change TTM	24.12 %	23.41 %	73.14 %	149.6 %	156.69 %
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	2,520	408	1,566	1,501	1,438
Return On Investment (TTM)	-90.62 %	-98.82 %	-19.69 %	-56.69 %	-91.3 %
CORZ's Overall Ranking	# 3915	# 2264	# 2127	# 284	# 3235
Seq. Investment Change TTM	22.01 %	-15.4 %	4.03 %	15.6 %	21.32 %
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	-1,358	-1,214	-286	-791	-1,103

CORZ Company Profile >> Back to CORZ Roi Comparisons >> See Annual CORZ Return On Investment

Return On Investment CORZ's Ranking
Within:	No.
Industry	# 3
Sector	# 36
Overall	# 3915

Return On Investment Statistics
High	Average	Low
-18.34 %	-113.72 %	-259.13 %
(Dec 31 2025)		(Mar 31 2023)

Financial Statements
Core Scientific Inc's II. Quarter Investments	$ 2,520 Millions	CORZ's Balance sheet
Core Scientific Inc's II. Quarter Income	$ -1,081 Millions	Quarterly CORZ's Income Statement
CORZ's Income by Division		See CORZ's Income by Division

CORZ Annual Return On Investment	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Investments in Millions	1,566	1,464	224	621	342
Y / Y Investment Growth	6.97 %	554.46 %	-63.97 %	81.47 %	-
Net Income in Millions	-289	-1,315	-246	-2,146	-32
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	-18.43 %	-89.81 %	-110.17 %	-345.68 %	-9.5 %

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Miscellaneous Financial Services Industry Roi Trends and Statistics
Financial Sector Return On Investment Statistics
Roi Trends for overall market
CORZ's Roi Ratio versus Miscellaneous Financial Services Industry, Financial Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for CORZ's Competitors
Subscribers only: Roi for Core Scientific Inc's Suppliers
Subscribers only: Return On Investment for CORZ's Customers

Other Ratios
CORZ's Roa	CORZ's Inventory Turnover Ratio	CORZ's Growth Rates	CORZ's Dividend Statistics
	CORZ's Profitability Ratios	CORZ's Asset Turnover Ratio	CORZ's Dividend Growth
CORZ's Roe	CORZ's Valuation Ratios	CORZ's Financial Strength Ratios	CORZ's Dividend Payout Ratio

Companies with similar Return On Investment at Jun 30 2026, within Financial Sector

ROI

Date modified: 2026-09-26T07:40:41+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.